The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes
Open accessAbstract
Interleukin 1β (IL-1β) is an important inflammatory mediator of type 2 diabetes. Here we show that oligomers of islet amyloid polypeptide (IAPP), a protein that forms amyloid deposits in the pancreas during type 2 diabetes, triggered the NLRP3 inflammasome and generated mature IL-1β. One therapy for type 2 diabetes, glyburide, suppressed IAPP-mediated IL-1β production in vitro. Processing of IL-1β initiated by IAPP first required priming, a process that involved glucose metabolism and was facilitated by minimally oxidized low-density lipoprotein. Finally, mice transgenic for human IAPP had more IL-1β in pancreatic islets, which localized together with amyloid and macrophages. Our findings identify previously unknown mechanisms in the pathogenesis of type 2 diabetes and treatment of pathology caused by IAPP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“that induce interleukin (IL)-1β release to recruit macrophages and enhance local islet inflammation ( 45 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [45]
Experimental — accuracy not yet measuredIn the citing paper
“A potential role for NLRP3 in promoting elevated levels of IL-1β in type 2 diabetes was also implied by the observation of NLRP3-dependent IL-1β secretion by mouse bone marrow-derived macrophages and dendritic cells in response to islet amyloid polypeptide (IAPP), which is deposited in the pancreas and associated with loss of β-cell function in type 2 diabetes61.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [61]
In the citing paper
“Interestingly, the anti-diabetic drug glyburide (Glibenclamide; Roche/Sanofi-Aventis) has been shown to block glucose-mediated secretion of IL-1β by mouse pancreatic islets62, as well as IL-1β production by macrophages in response to IAPP61, and NLRP3-deficient mice were more glucose tolerant than wild-type mice62.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [61]
In the citing paper
“In a separate study, no differences in IL-1β secretion were observed between wild-type and TXNIP-deficient bone marrow-derived macrophages in response to several NLRP3 stimuli, including MSU crystals and ATP61.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [61]
In the citing paper
“However, the role of TXNIP and ROS in NLRP3 activation has been challenged.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [61]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448
Self-citationGout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Self-citationTLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Bauernfeind, F. G., Horvath, G. L., Stutz, A., Alnemri, E. S., MacDonald, K. L., Speert, D. P., Fernandes‐Alnemri, T., Wu, J., Monks, B. G., Fitzgerald, K. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901363 · Cited by 3,087
Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Cited by
Sorted by citations
Items 901–1,000 of 1,001
Thompson, K. L., & Zimmerman, E. (2019) · JMIR Rehabilitation and Assistive Technologies · doi:10.2196/13966 · Cited by 15
Liu, Y., He, H., Fan, L., Yuan, J., Huang, H., Yang, W., Wang, L., Mo, Z., & Wang, F. (2019) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01712-4 · Cited by 14
Zhang, L., Chen, Q., Li, P., Yuan, L., Feng, Y., Wang, J., Mao, X., & Liu, L. (2019) · Chemical Communications · doi:10.1039/c9cc06264e · Cited by 14
Spectrum of Genetic Autoinflammatory Diseases Presenting with Cutaneous Symptoms
Bonnekoh, H., Butze, M., Kallinich, T., Kambe, N., Kokolakis, G., & Krause, K. (2020) · Acta Dermato Venereologica · doi:10.2340/00015555-3427 · Cited by 14
NLRP3 as a sensor of metabolism gone awry
Neuwirt, E., Gorka, O., Saller, B. S., Groß, C. J., Madl, T., & Groß, O. (2021) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2021.03.009 · Cited by 13
Qi, W., Liu, J., Yu, T., Huang, S., Song, R., & Qiao, Z. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.999020 · Cited by 14
Is there a role for the adaptive immune system in pancreatic beta cell failure in type 2 diabetes?
Westwell-Roper, C. Y., & Ehses, J. A. (2013) · Diabetologia · doi:10.1007/s00125-013-3151-2 · Cited by 14
“hIAPP, which aggregates to form islet amyloid deposits in type 2 diabetes (unlike the nonamyloidogenic rodent form), was recently identified as a novel activator of the NOD-, LRR- and pyrin domaincontaining protein (NLRP3) inflammasome (a multi-protein complex that generates active IL-1β from pro-IL-1β) in macrophages…”
BackgroundNSD1 Mitigates Caspase-1 Activation by Listeriolysin O in Macrophages
Sakhon, O. S., Victor, K. A., Choy, A., Tsuchiya, T., Eulgem, T., & Pedra, J. H. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075911 · Cited by 14
“that IL-6 signaling may be affected by IL-1b secretion downstream of caspase-1-dependent signaling pathways [52,53].”
BackgroundRamani, V., & Awasthi, S. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a1114-570r · Cited by 14
“Thus, signaling via TLR4 and the NLRP3 inflammasome is needed for an enhanced release of IL-1b and the exaggerated inflammation observed in acute injurious and inflammatory conditions, such as endotoxic shock, lung injury, and acute respiratory distress syndrome [9], and chronic conditions of arthritis [10], diabetes…”
C4b-binding Protein Protects β-Cells from Islet Amyloid Polypeptide-induced Cytotoxicity
Sjölander, J., Byman, E., Kułak, K. B., Nilsson, S. C., Zhang, E., Krus, U., Westermark, G. T., Storm, P., King, B. C., Renström, E., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.731141 · Cited by 14
“In addition to being directly cytotoxic, IAPP induces inflammasome-dependent inflammation in the islet (29), and it is therefore likely that IAPP can therefore indirectly cause up-regulation of C4BP expression in the islet.”
BackgroundAmyloid and immune homeostasis
Wang, Y., & Zhang, Y.-G. (2017) · Immunobiology · doi:10.1016/j.imbio.2017.10.038 · Cited by 14
Li, X., Chan, L., Li, X., Liu, C., Yang, G., Gao, J., Dai, M., Wang, Y., Xie, Z., Liu, J., et al. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7806 · Cited by 14
Ratajczak, M. Z., & Kucia, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.603942 · Cited by 14
Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents
Infante, M., Padilla, N., Alejandro, R., Caprio, M., Della‐Morte, D., Fabbri, A., & Ricordi, C. (2022) · Medicina · doi:10.3390/medicina58050571 · Cited by 17
Schommer, N., Gendron, N., Krauel, K., Bruggen, S. V., Jarrot, P., Maier, A., Chan, W., Langer, H. F., Duerschmied, D., Westermann, D., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf963 · Cited by 16
Immunometabolism Reframes Alzheimer’s Disease: From Systemic Dysmetabolism to Glial Rewiring
Bach, D., & Nguyen, L. L. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-026-01691-0 · Cited by 15
“Tricarboxylic-acid intermediates such as succinate, fumarate, and itaconate further encode metabolic “danger signals” that licensing NLRP3 inflammasome activation and sustaining chronic cytokine release (Masters et al. 2010; Tannahill et al. 2013 ).”
Pablo, S., Rodríguez‐Comas, J., Díaz-Catalán, D., Alcarraz‐Vizán, G., Castaño, C., Moreno‐Vedia, J., Montané, J., Párrizas, M., Servitja, J., & Novials, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-91311-2 · Cited by 13
NLRP3 as a therapeutic target in cyclophosphamide-associated toxicities
Srirangan, P., Shyam, M., Vidya, R., & Prince, S. E. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10479-2 · Cited by 13
MicroRNAs in inflammasomopathies
Saad, N., Duroux-Richard, I., Touitou, I., Jeziorski, É., & Apparailly, F. (2023) · Immunology Letters · doi:10.1016/j.imlet.2023.04.001 · Cited by 13
Redox Regulation of Nucleotide-Binding and Oligomerization Domain-Like Receptors Inflammasome
Ferrara, F., Pecorelli, A., & Valacchi, G. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0180 · Cited by 13
Les inflammasomes et les maladies humaines
Jamilloux, Y., Sève, P., & Henry, T. (2014) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2014.04.017 · Cited by 15
Glucose intolerance and pancreatic β-cell dysfunction in the anorecticanx/anxmouse
Lindfors, C., Katz, A., Selander, L., Johansen, J. E., Marconi, G., Schalling, M., Hökfelt, T. G. M., Berggren, P., Zaitsev, S. V., & Nilsson, I. A. K. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00081.2015 · Cited by 13
“, interleukin-1 , which inhibits insulin secretion (11, 33).”
BackgroundCull, A. H., & Rauh, M. J. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.5ri0317-083r · Cited by 13
“(IAPP)-induced activation of the inflammasome complex [111].”
Loss of NLRP3 Function Alleviates Murine Hepatic Graft-versus-Host Disease
Zhu, S., Shi, P., Lv, C., Li, H., Pan, B., Chen, W., Zhao, K., Yan, Z., Chen, C., Loake, G. J., et al. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.07.026 · Cited by 13
Zhou, Y., Li, W., Zhou, J., Chen, J., Wang, X., Cai, M., Li, F.-F., Xu, W. G., Carlsson, P., & Sun, Z. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.04.012 · Cited by 13
Zheng, Q., Zhao, H., Jia, D., Han, X., Liu, Z., & Zhao, M. (2021) · Mediators of Inflammation · doi:10.1155/2021/5571272 · Cited by 13
“Aberrant activation of NLRP3 inflammasome is closely related to the development of various diseases, including inflammatory diseases [31], infections [32], Alzheimer’s disease [33], and diabetes [34].”
The NLRP3 inflammasome is dispensable for ER stress-induced pancreatic β-cell damage in Akita mice
Wang, J., Song, M.-Y., Lee, J. Y., Kwon, K. S., & Park, B. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.09.009 · Cited by 14
Interleukin-1 antagonists for diabetes
Mandrup-Poulsen, T. R. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.804060 · Cited by 13
“The mechanisms of action have been suggested to involve ROS, dissociation of thioredoxin binding protein from the antioxidant thioredoxin as well as ER stress [13,16-19], but are debated [14], as are the mechanisms leading to inflammasome activation in general and detailed T.”
BackgroundInfluentialGevokizumab in type 1 diabetes mellitus: extreme remedies for extreme diseases?
Pafili, K., Παπάνας, Ν., & Maltezos, E. S. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.947026 · Cited by 13
“Hyperglycemia stimulates the production of the proinflammatory cytokine IL-1b [26-30].”
BackgroundInfluentialLee, M., Cho, Y., Lee, Y., Kang, E. S., Soo, B., & Lee, B. (2023) · Diabetes & Metabolism · doi:10.1016/j.diabet.2023.101427 · Cited by 12
Li, H., Li, Y., Zhang, Y., Li, T., Sa, Y., & Sun, W. (2023) · Gynecological Endocrinology · doi:10.1080/09513590.2023.2237116 · Cited by 14
“Various TXNIPs participate in regulating pancreatic β cell biology and the expression of insulin transcripts, including zinc finger Ebox-binding homeobox 1 (Zeb1) [35] and islet amyloid polypeptide protein (IAPP) [36].”
BackgroundYang, F., Dai, Z., Xue, M.-Y., Chen, X.-Y., Liu, J., Li, W., Xu, L., & Di, B. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00343 · Cited by 12
Dai, Z., Ben-Younis, A., Vlachaki, A., Raleigh, D. P., & Thalassinos, K. (2024) · Biophysical Chemistry · doi:10.1016/j.bpc.2024.107285 · Cited by 11
Krizhanovskii, C., Fred, R. G., Oskarsson, M. E., Westermark, G. T., & Welsh, N. (2017) · Upsala Journal of Medical Sciences · doi:10.1080/03009734.2017.1368745 · Cited by 11
“The present results, which showed that long-term palmitate-induced GPR40 activation augments the IAPP/insulin mRNA ratio, give further support for a deleterious role of GPR40 activation by the saturated fatty acid palmitate, as an increased IAPP/insulin ratio might accelerate the formation of islet amyloid deposits (1…”
BackgroundLin, H., Yang, M., Li, C., Lin, B., Deng, X., He, H., & Zhou, R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.822833 · Cited by 13
“development of several human diseases, including gout, type 2 diabetes (T2D), inflammatory bowel disease (IBD), atherosclerosis, neurodegenerative diseases and others (Martinon et al., 2006; Bauer et al., 2010; Duewell et al., 2010; Masters et al., 2010; Wen et al., 2012; Heneka et al., 2013; Guo et al., 2015).”
BackgroundPharmacological effects of Chinese medicine modulating NLRP3 inflammasomes in fatty liver treatment
Liu, T., Xu, G., Liang, L., Xiao, X., Zhao, Y., & Bai, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.967594 · Cited by 12
“homeostatic intracellular process that is activated by sensing the intracellular and extracellular PAMPs and DAMPs (Masters et al., 2010).”
BackgroundInfluentialTu, L., Noor, H., Cao, P., & Raleigh, D. P. (2014) · ACS Chemical Biology · doi:10.1021/cb500162w · Cited by 12
Screening for celiac disease in poorly controlled type 2 diabetes mellitus: worth it or not?
Kızılgül, M., Özçelik, Ö., Beysel, S., Akıncı, H., Kan, S., Uçan, B., Apaydın, M., & Çakal, E. (2017) · BMC Endocrine Disorders · doi:10.1186/s12902-017-0212-4 · Cited by 12
“High-fat diet related secretion of proinflammatory cytokines [9], endoplasmic reticulum stress via activation of toll-like receptors [10–12], activation of NLRP3 inflammasome upregulation [13] and promotion of glucose homeostasis by TNF-α blocker [14], the association of insulin resistance and dietary fatty acids with…”
BackgroundTargeting Islets: Metabolic Surgery Is More than a Bariatric Surgery
Chen, X., Zhang, J., & Zhou, Z. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03979-1 · Cited by 13
Templin, A. T., Mellati, M., Meier, D., Esser, N., Hogan, M. F., Castillo, J. J., Akter, R., Raleigh, D., Zraika, S., Hull, R., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05232-2 · Cited by 11
“Study of the relationship between islet amyloid formation and IL-1β signalling has focused primarily on the role of hIAPP in inducing IL-1β production from islet macrophages, thus promoting islet inflammation and beta cell loss [18, 19].”
BackgroundSelf-citationKuo, T.-Y., Wu, C., Lu, C., Lin, J., Liang, Y., Hsieh, C., Pei, D., & Chen, Y. (2020) · Medicine · doi:10.1097/md.0000000000022215 · Cited by 12
Particle Size of Latex Beads Dictates IL-1β Production Mechanism
Adachi, T., Takahara, K., Taneo, J., Uchiyama, Y., & Inaba, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068499 · Cited by 12
“In the NLRs, NOD-like receptor family, pyrin domain containing 3 (NLRP3), a component of NLRP3 inflammasome [3], has been revealed to be a potent sensor activated by particles such as silica [4], asbestos [5] and needle-like carbon nanotubes (CNT) [6] as well as endogenous monosodium urate crystals [7], cholesterin cr…”
BackgroundSater, A. A. A., & Philpott, D. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.10020-7 · Cited by 12
Rafey, A., Amin, A., Kamran, M. Z., Aziz, M. I., Athar, V., Niaz, S. I., & Pieters, L. A. C. (2022) · Molecules · doi:10.3390/molecules27196715 · Cited by 13
“3 [16] and caryophyllene oxide pose no.”
BackgroundZhou, N., Zhang, Y., Jiao, Y., Nan, J., Xia, A., Mu, B., Lin, G., Li, X., Yang, S., Yang, S., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111314 · Cited by 12
Clinical islet transplantation
Gill, R. G., & Bishop, N. H. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328355a2ec · Cited by 11
“Firstly, amyloid can trigger the activation of the inflammasome, resulting in the production of proinflammatory cytokines IL-1 and IL-6 [44].”
BackgroundAmylin and pramlintide modulate γ-secretase level and APP processing in lipid rafts
Mousa, Y. M., Abdallah, I. M., Hwang, M., Martin, D. R., & Kaddoumi, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-60664-5 · Cited by 11
Lage, S. L., Wong, C.-S., Amaral, E. P., Sturdevant, D. E., Hsu, D. C., Rupert, A. W., Wilson, E. M. P., Qasba, S. S., Naqvi, N., Laidlaw, E., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009435 · Cited by 11
Abachi, S., Pilon, G., Marette, A., Bazinet, L., & Beaulieu, L. (2021) · Food Reviews International · doi:10.1080/87559129.2021.2014861 · Cited by 11
“[56] Inactive pro-IL-1β is processed with caspase-1 leading to the secretion of active form of IL-1β.”
BackgroundInfluentialSaifee, D. H., Hudnall, M., & Raja, U. (2022) · Journal of Medical Internet Research · doi:10.2196/31659 · Cited by 12
Carvalho, V., Wang, Q., Xu, X., Liu, L., Jiang, W., Wang, X., Wang, J., Li, W., Chen, J., Li, T., et al. (2023) · The FASEB Journal · doi:10.1096/fj.202201879r · Cited by 11
Jin, S., Shim, W., Oh, B. J., Oh, S. H., Yu, S. J., Choi, J. M., Park, H. J., Park, J. H., & Kim, J. H. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13953 · Cited by 11
“Human islet amyloid polypeptide (hIAPP) provokes the secretion of IL-1b via inflammasome activation (2,3), and the release of proinflammatory cytokines and chemokines by macrophages, dendritic cells, and islets is amplified by IL-1 signaling (3).”
BackgroundTemplin, A. T., Meier, D. T., Willard, J. R., Wolden‐Hanson, T., Conway, K. A., Lin, Y., Gillespie, P. J., Bokvist, K. B., Attardo, G., Kahn, S. E., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4695-y · Cited by 11
Self-citationHutton, H., Alikhan, M. A., & Kitching, A. R. (2018) · Experientia supplementum · doi:10.1007/978-3-319-89390-7_8 · Cited by 11
The role of mitochondrial apoptotic pathway in islet amyloid-induced β-cell death
Wong, H. Y., Hui, Q., Hao, Z., Warnock, G. L., Woo, M., Luciani, D. S., & Marzban, L. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111424 · Cited by 11
Zhang, X., Liu, J., Huang, L., Yang, X., Petersen, R. B., Sun, Y., Gong, H., Zheng, L., & Huang, K. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.01.008 · Cited by 11
Hua, K., Chen, G.-M., Ho, C., Chen, M.-C., Chen, Y. S., Chen, W., Huang, J.-F., Perng, Y., & Lin, C.-C. (2012) · Natural Product Communications · doi:10.1177/1934578x1200701108 · Cited by 11
“Inflammation not only participates in host defense, but also controls the pathogenesis of many diseases including type 2 diabetes mellitus [14,23-25], atherosclerosis [15,26], obesity [14,26], silicosis [27], Alzheimer's disease [28], gout [16,24], and kidney disease [17,18].”
NLRP3 inflammasome: activation, regulation, and role in diseases
Zhou, R., Yan, Y., Jiang, W., & Jiang, H. (2017) · Scientia Sinica Vitae · doi:10.1360/n052016-00360 · Cited by 10
Qiao, Z., Han, J., Feng, H., Zheng, H., Wu, J., Gao, C., Yang, M., You, C., Liu, Z., & Wu, Z. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03292 · Cited by 10
NPC Natural Product Communications
Khana, S. I., Hester, J. P., Tekwania, B. L., Midiwob, J. O., Muhammada, I., Jaina, S. K., Jacoba, M. R., Walkera, L. A., Rahmana, A. A., & Samoylenkoa, V. (2011) · Cited by 11
Emerging Biomarkers and Nanobiosensing Strategies in Diabetes
Baranwal, A., Bansal, V., & Shukla, R. (2025) · Biosensors · doi:10.3390/bios15100639 · Cited by 14
Zhang, Y., Lv, J., Bai, J., Zhang, X., Wu, G., Lei, X., Li, W., & Zhang, Z. (2024) · Inflammation · doi:10.1007/s10753-023-01958-4 · Cited by 10
Wakeman, M., Tesfaye, L., Gregory, T., Leahy, E., Kendrick, B., & El‐Toukhy, S. (2024) · JMIR Formative Research · doi:10.2196/58221 · Cited by 11
Cutaneous manifestations of systemic autoinflammatory disorders
Bölükbasi, B., & Krause, K. (2015) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2015.05.002 · Cited by 10
Yang, L., Ge, Q., Ye, Z., Wang, L., Wang, L., Mashrah, M. A., & Pathak, J. L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.728458 · Cited by 12
“Glyburide is the first identified compound to prevent cryopyrin activation and microbial ligand-, DAMPs-, and crystal-induced IL-1β secretion (Lamkanfi et al., 2009; Masters et al., 2010).”
BackgroundZhao, L., Wang, S., Hu, Q., Jia, H., Xin, Y., Luo, L., & Meng, F. (2022) · Nanoscale · doi:10.1039/d1nr08090c · Cited by 10
Cichorium intybus: A Comprehensive Review on Its Pharmacological Activity and Phytochemistry
Qadir, I., Bazaz, M. R., Dar, R. M., Ovais, S., Mir, S. R., Zargar, M. I., & Rehman, M. U. (2022) · Springer eBooks · doi:10.1007/978-981-16-4959-2_12 · Cited by 10
Wang, N., Liang, Y., Ma, Q., Mi, J., Xue, Y., Yang, Y., Wang, L., & Wu, X. (2023) · Immunity Inflammation and Disease · doi:10.1002/iid3.854 · Cited by 10
“The expressions of genes IAPP, Slc30a8, Scg2, Chga, and Chgb were significantly reduced, which can protect islet B cells from apoptosis and can also change the insulin secretion defect caused by the inflammatory environment of pancreatic islets, thus improving the function of islet B cells and reducing the risk of TB…”
BackgroundInfluentialWang, Q., Li, H., Lu, H., Wang, S., Li, Y., Zhang, Z., Han, J., Yang, Z., Yang, Y., & Hong, Y. (2023) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2023.112043 · Cited by 10
Role of β‐cell autophagy in β‐cell physiology and the development of diabetes
Yasasilka, X. R., & Lee, M. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14184 · Cited by 12
“The mechanism of b -cell death by hIAPP oligomer is unclear, although ER stress 38 , ER translocon clogging 39 , in fl ammasome activation 40 or membrane pore formation 41,42 have been implicated.”
BackgroundWang, Y., Gong, G.-Q., Chen, S., Xiong, L.-Y., Zhou, X., Huang, X., & Kong, W.-J. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150915806 · Cited by 10
“We presumed that the NLRP3 inflammasome was activated resulting in an inflammatory cascade after inoculation, and then some endogenous NLRP3 agonists, for example, adenosine triphosphate and glucose, were released and activated more NLRP3 inflammasomes [19,21].”
BackgroundThe Role of Interleukin-1β in Destruction of Transplanted Islets
Chen, C., Rong, P., Yang, M. H., Ma, X., Feng, Z., & Wang, W. (2020) · Cell Transplantation · doi:10.1177/0963689720934413 · Cited by 11
Resende, D. P., da Costa, A. C., Rosa, L. P. D. S., Rodrigues, A. P. D. S., Santos, A. S. E. A. D. C., Cardoso, C. K. D. S., Sousa, J. D., Kipnis, A., Silveira, É. A., & Junqueira‐Kipnis, A. P. (2018) · Tuberculosis · doi:10.1016/j.tube.2018.11.003 · Cited by 10
Anti-inflammatory properties of antidiabetic agents
Xourgia, E., Tzouganatou, E.-M., Papazafiropoulou, A. K., & Melidonis, A. I. (2019) · World Journal of Meta-Analysis · doi:10.13105/wjma.v7.i4.129 · Cited by 11
Regulating against the dysregulation: new treatment options in autoinflammation
Kallinich, T. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0501-9 · Cited by 10
The Emerging Roles of IL-36, IL-37, and IL-38 in Diabetes Mellitus and its Complications
Huang, G., Li, M., Tian, X., Jin, Q., Mao, Y., & Li, Y. (2022) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530322666220113142533 · Cited by 9
Yue, L., Wang, P., Shi, Y., Cui, B., & Meng, J. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1022450 · Cited by 9
“The nod-like receptor pyrin domaincontaining 3 (NLRP3) inflammasome is an oligomeric complex that has been confirmed to be closely linked to many inflammatory and autoimmune diseases, such as atherosclerosis, gout, and diabetes mellitus (Masters et al., 2010; Davis et al., 2011; Karasawa and Takahashi, 2017; So and Ma…”
BackgroundIAPP - oligomerisation levels in plasma of people with type 2 diabetes
Rehn, F., Kraemer‐Schulien, V., Bujnicki, T., Bannach, O., Tschoepe, D., Stratmann, B., & Willbold, D. (2024) · Scientific Reports · doi:10.1038/s41598-024-70255-3 · Cited by 10
“Furthermore, IAPP is a potent activator of the NLRP3 inflammasome, leading to the production of the proinflammatory cytokine IL-1β, which is known to promote insulin resistance and ultimately damage β-cells in the long term 18 .”
Greasing the wheels of inflammasome formation: regulation of NLRP3 function by S-linked fatty acids
Williams, D. M., & Peden, A. A. (2025) · Biochemical Society Transactions · doi:10.1042/bst20241738 · Cited by 9
Liang, J.-Y., Yuan, X., Jiang, J., Zhang, P., & Kuang-Tan (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115167 · Cited by 13
Inflammasomes: novel therapeutic targets for metabolic syndrome?
Cao, P., Yang, Y., Zhang, N., Wang, B., & Gong, Z. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1569579 · Cited by 12
Jafarnezhad, F., Nazarzadeh, A., Bazavar, H., Keramat, S., Ryszkiel, I., & Stanek, A. (2025) · Nutrients · doi:10.3390/nu17162656 · Cited by 15
Post-translational modifications of NLRP3: to prime or not to prime?
Dufies, O., & Zanoni, I. (2025) · Trends in Immunology · doi:10.1016/j.it.2025.10.008 · Cited by 11
Qiu, Z., & Shang, D. (2025) · Metabolism Open · doi:10.1016/j.metop.2025.100418 · Cited by 9
“This drives the transcription of pro-inflammatory cytokines such as TNF-α and IL-6, and facilitating NLRP3 inflammasome assembly [70].”
Nurmi, K., Niemi, K., Kareinen, I., Silventoinen, K., Lorey, M. B., Chen, Y., Kouri, V., Parantainen, J., Juutilainen, T., Öörni, K., et al. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1323 · Cited by 9
Immune cell infiltration in the pancreas of type 1, type 2 and type 3c diabetes
Kattner, N. (2023) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188231185958 · Cited by 10
Association of inflammatory cytokines with obesity and pulmonary function testing
Khathlan, N. A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0294592 · Cited by 9
Yang, X., Xue, C., Chen, K.-Y., Gao, D., Wang, H., & Tang, C. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1339744 · Cited by 6
RETRACTED: Monocytes play different roles in stimulating T cells in obese diabetic individuals
Dai, X., Zhan, J., Demmy, T. A., Poordad, F. B., Fauceglia, P. L., Zhang, H., & Wu, L. (2015) · International Journal of Immunopathology and Pharmacology · doi:10.1177/0394632015598848 · Cited by 10
RetractedMeasuring IL-1β Processing by Bioluminescence Sensors II: The iGLuc System
Bartok, E., Kampes, M., & Hornung, V. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3566-6_6 · Cited by 9
Lau, Y.-S., Zhao, L., Zhang, C., Li, H., & Han, R.-Z. (2020) · Life Science · doi:10.1016/j.lfs.2020.118069 · Cited by 9
Gulotta, M. R., Lombino, J., Perricone, U., Simone, G. D., Mekni, N., Rosa, M. D., Diana, P., & Padova, A. (2020) · ChemMedChem · doi:10.1002/cmdc.202000259 · Cited by 7
Inflammasomes: Role in Disease Pathogenesis and Therapeutic Potential
Garanina, E. E., Martynova, E. V., Ivanov, K., Rizvanov, A. A., & Khaiboullina, S. F. (2020) · Učënye zapiski Kazanskogo universiteta. Seriâ Estestvennye nauki/Učënye zapiski Kazanskogo universiteta. Seriâ Estestvennye nauki/Učenye zapiski Kazanskogo gosudarstvennogo universiteta. Seriâ Estestvennye nauki · doi:10.26907/2542-064x.2020.1.80-111 · Cited by 10
Pan, C., Chen, Y., Wang, S., Li, M., & Qu, S. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24026 · Cited by 8
Kaneko, N., Kurata, M., Yamamoto, T., Shigemura, T., Agematsu, K., Yamazaki, T., Takeda, H., Sawasaki, T., Koga, T., Kawakami, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-70513-0 · Cited by 10
Regulated cell death in chronic kidney disease: current evidence and future clinical perspectives
Giuliani, K. T. K., Adams, B. C., Healy, H. G., & Kassianos, A. J. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1497460 · Cited by 11
Esumi, R., Funao, H., Kawamoto, E., Sakamoto, R., Ito-Masui, A., Okuno, F., Shinkai, T., Hane, A., Ikejiri, K., Akama, Y., et al. (2025) · JMIR Formative Research · doi:10.2196/65190 · Cited by 8
Huang, L., Zhang, F., Wang, Y., Wu, J., Wang, R., Wei, S., Li, X., Xu, N., Wang, Y., & Li, Y. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119842 · Cited by 8
Khalifa, J., Sulaimon, R., Côté‐Cyr, M., Nguyen, P. T., Peslherbe, G. H., Bourgault, S., & Gaudreault, R. (2025) · Biochemistry · doi:10.1021/acs.biochem.5c00139 · Cited by 8
Pancreatic Islet Cell Hormones: Secretion, Function, and Diabetes Therapy
Ma, J., Mao, L., Yang, L., Xie, Q., Fan, R., Lu, X., Huang, X., Tong, N., & Duan, Z. (2025) · MedComm · doi:10.1002/mco2.70359 · Cited by 11
“Similarly, islet amyloid polypeptide (IAPP), a proteinresponsibleforamyloiddepositioninthepancreasinT2D, activates the NLRP3 inflammasome and produces mature IL-1 β [203].”
Metadata
- Authors
- Masters, S. L., Dunne, A., Subramanian, S. L., Hull, R. L., Tannahill, G. M., Sharp, F. A., Becker, C., Franchi, L., Yoshihara, E., Chen, Z., Mullooly, N., Mielke, L. A., Harris, J., Coll, R. C., Mills, K. H. G., Mok, K. H., Newsholme, P., Nuñez, G., Yodoi, J., Kahn, S. E., Lavelle, E. C., & O'Neill, L. A. J.
- Affiliations
- Trinity College Dublin (IE)
- University of Washington (US)
- University of Michigan (US)
- Kyoto University (JP)
- University College Dublin (IE)
- Corresponding author
- Masters, Seth L
- ORCID
- Venue
- Nature Immunology
- Published
- 2010-09-12
- Volume
- 11
- Issue
- 10
- Pages
- 897-904
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- PMC
- PMC3103663
- OpenAlex
- W2034946303
- Cited by
- 1,330
- References
- 55
- Citations by year
- 2026: 58 · 2025: 57 · 2024: 64 · 2023: 75 · 2022: 71 · 2021: 99 · 2020: 100 · 2019: 95 · 2018: 82 · 2017: 83 · 2016: 73 · 2015: 101 · 2014: 95 · 2013: 112 · 2012: 83
- FWCI
- 35.67
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion, other-oa)
- eSpace (Curtin University) (submittedVersion)
- Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (AI063331, R56AI063331, R01AI063331, R37AI063331)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-75998, R01DK075998)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- NLRP3 inflammasome, amylin, IL-1β, type 2 diabetes, beta cell destruction, glibenclamide, LDL oxidation, glucose metabolism, inflammasome priming, pancreatic islets, macrophages, amyloid deposition
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Amyloid, Animals, Carrier Proteins, Cells, Cultured, Dendritic Cells, Diabetes Mellitus, Type 2, Glyburide, Humans, Hypoglycemic Agents, Islets of Langerhans, Macrophages, Mice, Inbred C57BL, Mice, Transgenic, Receptors, Cytoplasmic and Nuclear, Mice, Rats, Interleukin-1beta, Islet Amyloid Polypeptide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review